486 related articles for article (PubMed ID: 28103712)
1. Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
Rajkumar AP; Horsdal HT; Wimberley T; Cohen D; Mors O; Børglum AD; Gasse C
Am J Psychiatry; 2017 Jul; 174(7):686-694. PubMed ID: 28103712
[TBL] [Abstract][Full Text] [Related]
2. Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study.
Katon W; Pedersen HS; Ribe AR; Fenger-Grøn M; Davydow D; Waldorff FB; Vestergaard M
JAMA Psychiatry; 2015 Jun; 72(6):612-9. PubMed ID: 25875310
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients.
Nielsen J; Skadhede S; Correll CU
Neuropsychopharmacology; 2010 Aug; 35(9):1997-2004. PubMed ID: 20520598
[TBL] [Abstract][Full Text] [Related]
4. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.
Nielsen J; Nielsen RE; Correll CU
J Clin Psychopharmacol; 2012 Oct; 32(5):678-83. PubMed ID: 22926603
[TBL] [Abstract][Full Text] [Related]
5. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
[TBL] [Abstract][Full Text] [Related]
7. Treatment with antipsychotics and the risk of diabetes in clinical practice.
Kessing LV; Thomsen AF; Mogensen UB; Andersen PK
Br J Psychiatry; 2010 Oct; 197(4):266-71. PubMed ID: 20884948
[TBL] [Abstract][Full Text] [Related]
8. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
Ollendorf DA; Joyce AT; Rucker M
MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
[TBL] [Abstract][Full Text] [Related]
9. Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: a population-based study.
Liao CH; Chang CS; Wei WC; Chang SN; Liao CC; Lane HY; Sung FC
Schizophr Res; 2011 Mar; 126(1-3):110-6. PubMed ID: 21216567
[TBL] [Abstract][Full Text] [Related]
10. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
11. Association Between Antipsychotic Treatment and Advanced Diabetes Complications Among Schizophrenia Patients With Type 2 Diabetes Mellitus.
Wu CS; Gau SS
Schizophr Bull; 2016 May; 42(3):703-11. PubMed ID: 26721264
[TBL] [Abstract][Full Text] [Related]
12. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
Wu CS; Wang SC; Yeh IJ; Liu SK
J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study.
Baldur-Felskov B; Kjaer SK; Albieri V; Steding-Jessen M; Kjaer T; Johansen C; Dalton SO; Jensen A
Hum Reprod; 2013 Mar; 28(3):683-90. PubMed ID: 23223399
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
Pallava A; Chadda RK; Sood M; Lakshmy R
Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
[TBL] [Abstract][Full Text] [Related]
15. 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia.
Tiihonen J; Tanskanen A; Taipale H
Am J Psychiatry; 2018 Aug; 175(8):765-773. PubMed ID: 29621900
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus and antipsychotic treatment in the United Kingdom.
Carlson C; Hornbuckle K; DeLisle F; Kryzhanovskaya L; Breier A; Cavazzoni P
Eur Neuropsychopharmacol; 2006 Jul; 16(5):366-75. PubMed ID: 16356695
[TBL] [Abstract][Full Text] [Related]
17. Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics.
Mulcahy AW; Normand SL; Newcomer JW; Colaiaco B; Donohue JM; Lave JR; Keeler E; Sorbero MJ; Horvitz-Lennon M
Psychiatr Serv; 2017 Dec; 68(12):1280-1287. PubMed ID: 28859580
[TBL] [Abstract][Full Text] [Related]
18. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
Leslie DL; Rosenheck RA
Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
[TBL] [Abstract][Full Text] [Related]
19. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
20. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
